RecruitingNCT06535802

iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men

Sponsor

Mayo Clinic

Enrollment

53 participants

Start Date

Nov 20, 2023

Study Type

OBSERVATIONAL

Conditions

This study is being done to determine the acceptance and effectiveness of a virtual robot assistant model at a urology clinic.

Max Age: 80 Years

AIM 1: iCCaRE Consortium consumer advocates
Clinicians who are part of the Translational Research \& Clinical Intervention Services (TRaCIS)
AIM 2 ALPHA TESTING: iCCaRE consumer advocates \[2 Community Advisory Board (CAB) and 1 non-CAB\]
AIM 2 BETA TESTING-PATIENTS:
An African American/Black male
A patient who has been diagnosed with prostate cancer in Florida at any time in their life, and/or within the previous 6 months has had an abnormal Prostate-Specific Antigen (PSA) lab value and/or Digital Rectal Examination (DRE)
Minimum age of 30 years old
Consent to participating in the intervention

AIM 2 BETA TESTING-PATIENTS:
Patients who are not African American/Black males
Patients not diagnosed with prostate cancer in Florida at any time in their life, or within the previous 6 months has not had a normal PSA lab value and/or DRE
Older than 80 years old
Are not willing to consent